PON1 - paraoxonase 1 Gene
Also Known as ESA; PON; MVCD5
Species: Homo sapiens
About PON1
This gene has 4 transcripts (splice variants), 269 orthologues, 2 paralogues and is associated with 3 phenotypes. Restricted expression toward liver (RPKM 222.6).
Summary
This gene encodes a member of the paraoxonase family of Enzymes and exhibits lactonase and ester hydrolase activity. Following synthesis in the kidney and liver, the enzyme is secreted into the circulation, where it binds to high density lipoprotein (HDL) particles and hydrolyzes thiolactones and xenobiotics, including paraoxon, a metabolite of the Insecticide parathion. Polymorphisms in this gene may be associated with coronary artery disease and diabetic retinopathy. The gene is found in a cluster of three related paraoxonase genes on chromosome 7. [provided by RefSeq, Aug 2017]
PON1 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_000446.7 | NP_000437.3 | serum paraoxonase/arylesterase 1 precursor |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables acyl-L-homoserine-lactone lactonohydrolase activity |
IDA
IDA: Inferred from direct assay
|
15772423 | GOA |
| enables aryldialkylphosphatase activity |
IDA
IDA: Inferred from direct assay
|
7638166 | GOA |
| enables arylesterase activity |
IDA
IDA: Inferred from direct assay
|
7638166 | GOA |
| enables calcium ion binding |
IDA
IDA: Inferred from direct assay
|
15098021 | GOA |
| enables phospholipid binding |
IDA
IDA: Inferred from direct assay
|
10479665 | GOA |
| enables protein homodimerization activity |
IPI
IPI: Inferred from physical interaction
|
15772423 | GOA |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| involved in carboxylic acid catabolic process |
IDA
IDA: Inferred from direct assay
|
7638166 | GOA |
| involved in lactone catabolic process |
IDA
IDA: Inferred from direct assay
|
15772423 | GOA |
| NOT involved in negative regulation of plasma lipoprotein oxidation |
IDA
IDA: Inferred from direct assay
|
15342686 | GOA |
| involved in organophosphate catabolic process |
IDA
IDA: Inferred from direct assay
|
7638166 | GOA |
| involved in phosphatidylcholine metabolic process |
IDA
IDA: Inferred from direct assay
|
15721011 | GOA |
| involved in positive regulation of cholesterol efflux |
IDA
IDA: Inferred from direct assay
|
15721011 | GOA |
| involved in response to toxic substance |
IDA
IDA: Inferred from direct assay
|
15772423 | GOA |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| located in extracellular space |
IDA
IDA: Inferred from direct assay
|
7638166 | GOA |
| part of high-density lipoprotein particle |
IDA
IDA: Inferred from direct assay
|
15721011 | GOA |
| part of spherical high-density lipoprotein particle |
IDA
IDA: Inferred from direct assay
|
16682745 | GOA |
PON1 Protein Structure
Arylesterase: Arylesterase (168 - 253)
- 0
- 100
- 200
- 300
- 355 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
serum paraoxonase/arylesterase 1 |
|
PON1 Antibodies
| Cat. No. | Product Name | Application | Reactivity |
|---|---|---|---|
| HY-P81921 | PON1 Antibody (YA1666) | WB, IHC-P, IP | Human |
| HY-P84222 | PON1 Antibody (YA3919) | WB, IHC-P, ICC/IF, FC, ELISA | Human |
| HY-P84222A | PON1 Antibody (YA3919)(PBS only) | WB, IHC-P, ICC/IF, FC, ELISA | Human |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Microvascular Complications Of Diabetes 5 |
|
|
| Amyotrophic Lateral Sclerosis 1 |
|
|
| Multiple Chemical Sensitivity |
|
|
| Coronary Stenosis |
|
|
| Carotid Artery Disease |
|
|
| Persian Gulf Syndrome |
|
|
| Lipoprotein Quantitative Trait Locus |
|
|
| Ischemia |
|
|
| Aortic Valve Insufficiency |
|
|
| End Stage Renal Disease |
|
|
| Arteriosclerosis |
|
|
| Myocardial Infarction |
|
|
| Vascular Disease |
|
|
| Uremia |
|
|
| Atherosclerosis Susceptibility |
|
|
| Vascular Dementia |
|
|
| Retinal Disease |
|
|
| Hyperhomocysteinemia |
|
|
| Diabetes Mellitus |
|
|
| Cerebrovascular Disease |
|
|
| Antiphospholipid Syndrome |
|
|
| Familial Hypercholesterolemia |
|
|
| Chronic Kidney Disease |
|
|
| Heart Disease |
|
|
| Familial Hyperlipidemia |
|
|
| Cardiovascular System Disease |
|
|
| Type 2 Diabetes Mellitus |
|
|
| Diabetic Neuropathy |
|
|
| Acute Tympanitis |
|
|
| Lipid Metabolism Disorder |
|
|
| Otosclerosis |
|
|
| Coronary Heart Disease 1 |
|
|
| Hyperlipidemia, Familial Combined, 3 |
|
|
| Fabry Disease |
|
|
| Acute Myocardial Infarction |
|
|
| Smith-Lemli-Opitz Syndrome |
|
|
| Focal Segmental Glomerulosclerosis |
|
|
| Hypothyroidism |
|
|
| Kidney Disease |
|
|
| Dirofilariasis |
|
|
| Type 1 Diabetes Mellitus |
|
|
| Hypoalphalipoproteinemia, Primary, 2 |
|
|
| Pre-Eclampsia |
|
|
| Beta-Thalassemia |
|
|
| Dementia |
|
|
| Nephrotic Syndrome |
|
|
| Hypertension, Essential |
|
|
| Prader-Willi Syndrome |
|
|
| Stroke, Ischemic |
|
|
| Neural Tube Defects |
|
|
| Autism |
|
|
| Glycogen Storage Disease |
|
|
| Systemic Lupus Erythematosus |
|
|
| Asthma |
|
|
| Hemochromatosis, Type 1 |
|
|
| Cataract |
|
|
| Behcet Syndrome |
|
|
| Tobacco Addiction |
|
|
| Body Mass Index Quantitative Trait Locus 11 |
|
|
| Alzheimer Disease, Familial, 1 |
|
|
| Deficiency Anemia |
|
|
| Parkinson Disease, Late-Onset |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Mus musculus | PON1 | MGD | MGI:103295 |
| Felis catus | PON1 | VGNC | VGNC:68957 |
| Macaca mulatta | PON1 | VGNC | VGNC:76219 |
| Rattus norvegicus | PON1 | RGD | RGD:620062 |
| Bos taurus | PON1 | VGNC | VGNC:33160 |
| Canis familiaris | PON1 | VGNC | VGNC:44812 |
| Others | PON1 | NCBI |